Technology that doesn’t just sound good. It’s clinically great.
Validation at leading institutions
Hemodynamics and
Heart Failure
Healthcare Innovation, Practice Transformation Lab
PI: Curtiss Stinis, MD, FACC, FSCAI
Christine Shen, MD
Steven Romero, MD
Atrial Fibrillation and other Heart Arrythmias
PI: Roosevelt Gilliam III, MD, Professor of Medicine, University of South Carolina
“MindMics can detect heart rhythms even as complex as atrial fibrillation with an accuracy of gold standard ECG”
AI for Cardiovascular Monitoring
and Path Toward FDA
The Center for Innovation at RWJ University
PI: Prof. Partho P. Sengupta, MD, FACC, FASE
Prof. Naveena Yanamala, Director of DS & ML Research
Published Clinical Validation
MindMics technology is validated by leading clinical institutions and incubated with trusted organizations
In-ear Infrasonic Hemodynography for Cardiac Arrhythmia Assessment Beyond ECG. Source
“Hearing the Heart” - Validation of a Novel Digital Health Earbud Technology to Measure Cardiac Time Intervals Through Infrasonic Hemodynography. Source
Can a Novel Earbud Technology Detect Severe Aortic Stenosis? Modernizing the Wiggers Diagram Through Infrasonic Hemodynography Synchronized With Echocardiography and Cardiac Catheterization. Source
In-ear infrasonic hemodynography with a digital health device for cardiovascular monitoring using the human audiome. Source
Can a novel earbud detect aortic stenosis murmur before and after transcatheter aortic valve replacement? Source
We are creating biometric solutions with the clinical precision of those you may find in a hospital but are a part of your everyday life. Our clinical study program, developed in concert with leading researchers and world renowned medical institutions, demonstrates how we stack up.
MindMics is pursuing a clinically rigorous development pathway to ensure that platform effectiveness is more than skin deep. Evidence to date demonstrates clinical effectiveness of the MindMics technology, infrasonic hemodynography (IH), to monitor detailed cardiac function in a consumer wearable, including the potential to identify complex cardiac disorders like atrial fibrillation and aortic stenosis. Previous studies demonstrate that MindMics can measure the time between heartbeats with equivalent accuracy to the gold standard ECG – even for heartbeats as complex as atrial fibrillation. This translates into providing consumers with the ability to measure heart rate and heart rate variability with the simplicity of donning earbuds and the accuracy of having an ECG scan.
In the news at the American Heart Association (AHA)
Two studies presented at the 2021 American Heart Association meeting demonstrate additional findings supporting the effectiveness of the MindMics earbud technology to measure cardiac functions with similar accuracy to what currently can be obtained only through invasive procedures. Principal investigator, Sanjeev Bhavanani, MD, Scripps Health, stated, “We demonstrate high correlation between bio-signals from MindMics earbuds, echocardiography, and cardiac catheterizations, specifically in capturing cardiovascular performance measures.”
In a second study, MindMics earbud technology demonstrated the potential to detect aortic stenosis. “This represents a promising development to detect valvular disease independent of invasive and expensive methods like echocardiography and cardiac catheterization,” concluded investigators.
Additional studies are ongoing and supportive of a parallel commercialization pathway to seek FDA clearance for use of the MindMics system in clinical situations. The use of MindMics for measurement of cardiovascular function is currently investigational. The safety and effectiveness for this purpose has not been reviewed by the United States Food and Drug Administration (FDA).
MindMics Awarded a grant to work on Vascular aging using infrasonic hemodynography embedded into everyday earbuds
Motivation
Physiological aging and cardiovascular risk factors lead to structural and functional alterations in large arteries. Aortic stiffness is the best predictor of cardiovascular morbidity and mortality. Invasive measurements of arterial stiffness are not feasible in routine clinical use.
TECHNOLOGY YOU CAN TRUST
“MindMics can detect heart rhythms even as complex as atrial fibrillation with an accuracy of gold standard ECG”
PI: Roosevelt Gilliam III, MD, Professor of Medicine, University of South Carolina
The Impressive Company We Keep
